Donna Mazloomdoost
Papers
4
Total Citations
80
H-Index
3
About
Donna Mazloomdoost is a leading researcher in female pelvic medicine and reconstructive surgery, with a focused expertise in optimizing surgical outcomes for pelvic organ prolapse (POP). Her work critically evaluates the comparative effectiveness of robotic versus vaginal surgical approaches, as well as innovative pain management strategies. In a landmark randomized controlled trial, she demonstrated that liposomal bupivacaine significantly reduces postoperative pain following robotic sacrocolpopexy with posterior repair, a study that has garnered 32 citations and influenced perioperative protocols. Her comparative research on vaginal reconstruction versus robotic sacrocolpopexy (27 citations) revealed that while quality-of-life outcomes are similar, the vaginal route may offer advantages in reduced narcotic use and lower pain scores. Mazloomdoost has also explored patient perspectives, investigating how media exposure and marketing shape women’s knowledge and preferences regarding robotic surgery for POP (19 citations). By bridging clinical outcomes with patient education, her work empowers both surgeons and patients to make informed, evidence-based decisions in the rapidly evolving field of minimally invasive pelvic reconstruction.
Research Focus
Key Achievements
Top Papers
- 1Liposomal Bupivacaine During Robotic Colpopexy and Posterior Repair32 citations · 2017
- 2
- 3
- 4